clinical_trials
First At-Home Thyroid Eye Disease Shot Approved
Confidence86·multiple reportsImportance88NP-EVT-20261016-94A8DD8
(MedPage Today) -- The FDA approved satralizumab (Enspryng), the first and only at-home subcutaneous treatment option for adults with thyroid eye disease (TED), developer Roche announced on Thursday. The first-in-class drug is a humanized monoclonal...
Read the original at the primary source
First At-Home Thyroid Eye Disease Shot Approved
10/16/2026, 6:34:47 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —